Epistaxis Market Report: Global Epistaxis Market Report Examines Latest Trends and Key Drivers Supporting Growth through 2017-2026

Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This FactMR report analyzes the expansion of global Epistaxis Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

The scope of FactMR’s report is to analyze the global epistaxis market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global epistaxis market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to epistaxis.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=344

Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane.

Innovative Surgeries to Underscore Lucrative Growth Opportunities

Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.

Endoscopic litigation of sphenopalatine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.

To know the Latest Trends in Epistaxis Market, Visit – https://www.factmr.com/report/344/epistaxis-market

Anterior Indication to Represent a Leading Segment

With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

Table of Contents

Chapter 1 Global Outlook

Chapter 2 Global Epistaxis Market – Executive Summary

Chapter 3 Global Epistaxis Market Overview

3.1 Introduction

3.1.1 Global Epistaxis Market Taxonomy

3.1.2 Global Epistaxis Market Definition

3.2 Global Epistaxis Market Size (US$ Mn) and Forecast, 2012-2026

3.2.1 Global Epistaxis Market Y-o-Y Growth

3.3 Global Epistaxis Market Dynamics

3.4 Supply Chain

3.5 Cost Structure

3.6 Epistaxis Epidemiology

3.7 Key Regulations

3.8 Patent Analysis

3.9 PESTL Analysis

3.10 Product Lifecycle

3.11 Pricing Analysis

3.12 Service Provider List

Continued……………………………………………..

To Buy Global Market Research Report, Check the link – https://www.factmr.com/checkout/344/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us –

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/